ResearcherHarvard UniversityNo recent work listed
Akira Nakamura
Matched on ORCID iD 0000-0002-4397-7810; OpenAlex author ID A5101397704. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 25
2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: 1 paper · 2019: 3 papers
Papers 6
- Elective nodal irradiation with simultaneous integrated boost stereotactic body radiotherapy for pancreatic cancer: Analyses of planning feasibility and geomet… Co-author DOI 10.1002/acm2.12528↗
- Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion. Co-author DOI 10.1200/cci.18.00079↗
- Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies optimum intervention strategies. First author DOI 10.1371/journal.pone.0215409↗
- Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer. First author DOI 10.1186/s13014-018-1063-5↗
- Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling. Co-author DOI 10.1158/0008-5472.can-16-1208↗
- Phase II study of radiation therapy combined with weekly low-dose gemcitabine for locally advanced, unresectable pancreatic cancer. Co-author DOI 10.1097/coc.0b013e3181c4c7a8↗
Closest collaborators
The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Kimiyo N. Yamamoto · 3 shared papers, 2017–2019 · strength 0.27
- Paper Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion. DOI 10.1200/cci.18.00079↗
- Paper Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies op… DOI 10.1371/journal.pone.0215409↗
- Paper Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling. DOI 10.1158/0008-5472.can-16-1208↗
- Hiroshi Haeno · 3 shared papers, 2017–2019 · strength 0.27
- Paper Stochastic Evolution of Pancreatic Cancer Metastases During Logistic Clonal Expansion. DOI 10.1200/cci.18.00079↗
- Paper Computational modeling of pancreatic cancer patients receiving FOLFIRINOX and gemcitabine-based therapies identifies op… DOI 10.1371/journal.pone.0215409↗
- Paper Personalized Management of Pancreatic Ductal Adenocarcinoma Patients through Computational Modeling. DOI 10.1158/0008-5472.can-16-1208↗
- Franziska Michor A · 2 shared papers, 2019 · strength 0.20
- Theodore Sunki Hong · 1 shared paper, 2019 · strength 0.12
- Jennifer Yon-Li Wo · 1 shared paper, 2019 · strength 0.12
- Keiko Shibuya · 2 shared papers, 2011–2018 · strength 0.10
- Masahiro Hiraoka · 2 shared papers, 2011–2018 · strength 0.10
- Chung Yin Kong · 1 shared paper, 2019 · strength 0.08
- Angela C. Tramontano · 1 shared paper, 2019 · strength 0.08
- Tetsunosuke Shimizu · 1 shared paper, 2019 · strength 0.08
- Kazuhisa Uchiyama · 1 shared paper, 2019 · strength 0.08
- Chin Hur · 1 shared paper, 2019 · strength 0.08
- Ryo Ashida · 1 shared paper, 2018 · strength 0.07
- Toshihiko Masui · 1 shared paper, 2018 · strength 0.07
- Masashi Kanai · 1 shared paper, 2018 · strength 0.07
- Takashi Mizowaki · 1 shared paper, 2018 · strength 0.07
- Yökö Gotö · 1 shared paper, 2018 · strength 0.07
- Yuzo Kodama · 1 shared paper, 2018 · strength 0.07
- Kyoichi Takaori · 1 shared paper, 2018 · strength 0.07
- Lauren M. Rosati · 1 shared paper, 2017 · strength 0.07
- Subhajyoti De · 1 shared paper, 2017 · strength 0.07
- Minoru Oshima · 1 shared paper, 2017 · strength 0.07
- Joseph M. Herman · 1 shared paper, 2017 · strength 0.07
- Shinichi Yachida · 1 shared paper, 2017 · strength 0.07
- Christine A. Iacobuzio–Donahue · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.